Skip to content

United States ex rel. Ge v. Takeda Pharmaceutical Company Limited

Petition for certiorari denied on October 6, 2014

Docket No. Op. Below Argument Opinion Vote Author Term
13-1236 1st Cir. N/A N/A N/A N/A OT 2014

Issue: Whether the "freely given" standard for the amendment of pleading embodied in Federal Rule of Civil Procedure 15(a), and espoused in Foman v. Davis, applies to a motion to amend timely filed after the entry of judgment, as held by the Third, Fourth, Fifth, Sixth, and Tenth Circuits, or whether the entry of judgment categorically forecloses any application of Rule 15(a), as held by the First, Seventh, Ninth, and Eleventh Circuits.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
04/10/2014Petition for a writ of certiorari filed. (Response due May 15, 2014)
04/18/2014Order extending time to file response to petition to and including June 16, 2014.
06/16/2014Brief of respondents Takeda Pharmaceutical Company Limited, et al. in opposition filed.
06/27/2014Reply of petitioner United States, ex rel. Helen Ge filed.
07/02/2014DISTRIBUTED for Conference of September 29, 2014.
10/06/2014Petition DENIED.